Mir-146B Accelerates Osteoarthritis Progression by Targeting Alpha-2-macroglobulin

X. Liu,Hang Fang,R. Zhang,Tim Huang,Chun Zeng,Daozhang Cai
DOI: https://doi.org/10.1016/j.joca.2019.02.249
IF: 7.507
2019-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: Osteoarthritis (OA) is a common chronic degenerative diseases characterized by cartilage degeneration. Research suggests that microRNAs 146b and alpha-2-macroglobulin (A2M) might play important roles in OA. The aim of this study was to identify the role of miR-146b and its effects on A2M expression during OA progression. Methods: Functional analysis of the effects of miR-146b on chondrocytes was performed after IL-1β treatment and miRNA transfection. Cell viability, mRNA expressions and productions of proteolytic enzymes were also assessed. The expression of miR-146b and alpha-2-macroglobulin (A2M) mRNA was measured by qRT-PCR. Luciferase assays were performed to assess the targeting effect of miR-146b on the 3’-untranslated region of A2M. Protein expression was measured with western blotting. Results: Through gain- and loss-of-function analyses, we found that miR-146b significantly affected chondrocytes viability and the expression of matrix synthesis genes. Downregulation of miR-146b dramatically inhibited caspase activation and proteolytic enzymes expression. Dual luciferase activity demonstrated that A2M is a direct target for miR-146b, and its expression was negatively regulated by miR-146b. More importantly, intra-articular injection of antago-miR-146b effectively protected mice with osteoarthritis from cartilage degradation and proteoglycan loss compared with controls. Conclusions: Altogether, our findings reveal a novel miRNA-dependent regulatory and functional pathway for osteoarthritis development and demonstrate the potential utility of miR-146b and A2M as therapeutic targets for osteoarthritis.
What problem does this paper attempt to address?